Cargando…
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
Empagliflozin is an oral treatment for type 2 diabetes mellitus (T2DM), one of the leading causes of death in the US and around the world. Recently, the EMPA-REG OUTCOME study has shown that empagliflozin added to standard of care treatment reduced the risk of cardiovascular (CV) events in patients...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306110/ https://www.ncbi.nlm.nih.gov/pubmed/27837465 http://dx.doi.org/10.1007/s13300-016-0211-x |